Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Detection of minimal residual disease by mutant p53 immunocytochemistry in acute myelogenous leukemia.

Medical and pediatric oncology - 1 Feb 2000

Kattamis A C, Tsangaris G T, Vamvoukakis J, Moschovi M, Grafakos S, Tzortzatou-Stathopoulou F

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adolescent
Share to Genes, p53
Share to Immunohistochemistry
Share to Leukemia, Myeloid, Acute

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Mutation

Share to Recurrence

Source

Identifiers

PMID: 10657882
DOI: 10.1002/(sici)1096-911x(200002)34:2<153::aid-mpo18>3.0.co;2-q

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Detection of minimal residual disease by mutant p53 immunocytochemistry in acute myelogenous leukemia.PMID 10657882Read ↗

Detection of minimal residual disease in leukemias: a critical approach.Semantic proximity Read ↗

Detection of minimal acute myeloid leukemia cells in bone marrow by probing for mutated ras oncogenes using the polymerase chain reaction.Semantic proximity Read ↗

Detection of minimal residual disease in multiple myeloma and acute leukaemia.Semantic proximity Read ↗

Detection of H-RAS point mutation in myeloperoxidase negative acute myelogenous leukaemia (FAB; AML-MO).Semantic proximity Read ↗

N-ras mutation in acute myeloid leukemia: incidence, prognostic significance and value as a marker of minimal residual disease.Semantic proximity Read ↗

Detection of minimal residual disease in acute myelogenous leukemia.Semantic proximity Read ↗

Detection of minimal residual disease in hematologic malignancies by real-time quantitative PCR: principles, approaches, and laboratory aspectsSemantic proximity Read ↗

Minimal residual disease in acute myelogenous leukemia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.